APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vigabatrin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vigabatrin Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchVigabatrin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Vigabatrin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Vigabatrin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vigabatrin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Vigabatrin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Vigabatrin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vigabatrin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vigabatrin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vigabatrin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vigabatrin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vigabatrin include Sanofi, Novartis, Upsher-Smith, Perrigo, Lundbeck, Grindeks, Endo International, Dr. Fisher Farma and Cipla, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vigabatrin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vigabatrin, also provides the sales of main regions and countries. Of the upcoming market potential for Vigabatrin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vigabatrin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vigabatrin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vigabatrin sales, projected growth trends, production technology, application and end-user industry.

Vigabatrin Segment by Company

Sanofi

Novartis

Upsher-Smith

Perrigo

Lundbeck

Grindeks

Endo International

Dr. Fisher Farma

Cipla

Benta Pharma Industries

Amneal Pharma

Vigabatrin Segment by Type

Tablet

Powder

Vigabatrin Segment by Application

Partial-Onset Seizures

Refractory Complex Partial Seizures

Infantile Spasms (IS)

Vigabatrin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vigabatrin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vigabatrin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vigabatrin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vigabatrin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vigabatrin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vigabatrin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vigabatrin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Powder Major Manufacturers Table 4. Global Vigabatrin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Partial-Onset Seizures Major Manufacturers Table 6. Refractory Complex Partial Seizures Major Manufacturers Table 7. Infantile Spasms (IS) Major Manufacturers Table 8. Vigabatrin Industry Trends Table 9. Vigabatrin Industry Drivers Table 10. Vigabatrin Industry Opportunities and Challenges Table 11. Vigabatrin Industry Restraints Table 12. Global Vigabatrin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Vigabatrin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Vigabatrin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Vigabatrin Revenue Market Share by Region (2021-2026) Table 16. Global Vigabatrin Revenue Market Share by Region (2027-2032) Table 17. Global Vigabatrin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Vigabatrin Sales by Region (2021-2026) & (K Units) Table 19. Global Vigabatrin Sales by Region (2027-2032) & (K Units) Table 20. Global Vigabatrin Sales Market Share by Region (2021-2026) Table 21. Global Vigabatrin Sales Market Share by Region (2027-2032) Table 22. Global Vigabatrin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Vigabatrin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Vigabatrin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Vigabatrin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Vigabatrin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Vigabatrin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Vigabatrin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Vigabatrin Manufacturers, Product Type & Application Table 30. Global Vigabatrin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Vigabatrin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Vigabatrin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Vigabatrin Revenue Market Share by Type (2021-2026) Table 37. Global Vigabatrin Revenue Market Share by Type (2027-2032) Table 38. Global Vigabatrin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Vigabatrin Sales by Type (2021-2026) & (K Units) Table 40. Global Vigabatrin Sales by Type (2027-2032) & (K Units) Table 41. Global Vigabatrin Sales Market Share by Type (2021-2026) Table 42. Global Vigabatrin Sales Market Share by Type (2027-2032) Table 43. Global Vigabatrin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Vigabatrin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Vigabatrin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Vigabatrin Revenue Market Share by Application (2021-2026) Table 49. Global Vigabatrin Revenue Market Share by Application (2027-2032) Table 50. Global Vigabatrin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Vigabatrin Sales by Application (2021-2026) & (K Units) Table 52. Global Vigabatrin Sales by Application (2027-2032) & (K Units) Table 53. Global Vigabatrin Sales Market Share by Application (2021-2026) Table 54. Global Vigabatrin Sales Market Share by Application (2027-2032) Table 55. Global Vigabatrin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vigabatrin Price by Application (2027-2032) & (US$/Unit) Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Sanofi Vigabatrin Product Portfolio Table 61. Sanofi Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis Vigabatrin Product Portfolio Table 66. Novartis Recent Development Table 67. Upsher-Smith Company Information Table 68. Upsher-Smith Business Overview Table 69. Upsher-Smith Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Upsher-Smith Vigabatrin Product Portfolio Table 71. Upsher-Smith Recent Development Table 72. Perrigo Company Information Table 73. Perrigo Business Overview Table 74. Perrigo Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Perrigo Vigabatrin Product Portfolio Table 76. Perrigo Recent Development Table 77. Lundbeck Company Information Table 78. Lundbeck Business Overview Table 79. Lundbeck Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Lundbeck Vigabatrin Product Portfolio Table 81. Lundbeck Recent Development Table 82. Grindeks Company Information Table 83. Grindeks Business Overview Table 84. Grindeks Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Grindeks Vigabatrin Product Portfolio Table 86. Grindeks Recent Development Table 87. Endo International Company Information Table 88. Endo International Business Overview Table 89. Endo International Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Endo International Vigabatrin Product Portfolio Table 91. Endo International Recent Development Table 92. Dr. Fisher Farma Company Information Table 93. Dr. Fisher Farma Business Overview Table 94. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Dr. Fisher Farma Vigabatrin Product Portfolio Table 96. Dr. Fisher Farma Recent Development Table 97. Cipla Company Information Table 98. Cipla Business Overview Table 99. Cipla Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Cipla Vigabatrin Product Portfolio Table 101. Cipla Recent Development Table 102. Benta Pharma Industries Company Information Table 103. Benta Pharma Industries Business Overview Table 104. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Benta Pharma Industries Vigabatrin Product Portfolio Table 106. Benta Pharma Industries Recent Development Table 107. Amneal Pharma Company Information Table 108. Amneal Pharma Business Overview Table 109. Amneal Pharma Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Amneal Pharma Vigabatrin Product Portfolio Table 111. Amneal Pharma Recent Development Table 112. North America Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Vigabatrin Sales by Type (2021-2026) & (K Units) Table 115. North America Vigabatrin Sales by Type (2027-2032) & (K Units) Table 116. North America Vigabatrin Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Vigabatrin Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Vigabatrin Sales by Application (2021-2026) & (K Units) Table 121. North America Vigabatrin Sales by Application (2027-2032) & (K Units) Table 122. North America Vigabatrin Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Vigabatrin Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Vigabatrin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Vigabatrin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Vigabatrin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Vigabatrin Sales by Country (2021-2026) & (K Units) Table 129. North America Vigabatrin Sales by Country (2027-2032) & (K Units) Table 130. North America Vigabatrin Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Vigabatrin Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Vigabatrin Revenue (2021-2032) & (US$ Million) Table 133. Canada Vigabatrin Revenue (2021-2032) & (US$ Million) Table 134. Europe Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Vigabatrin Sales by Type (2021-2026) & (K Units) Table 137. Europe Vigabatrin Sales by Type (2027-2032) & (K Units) Table 138. Europe Vigabatrin Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Vigabatrin Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Vigabatrin Sales by Application (2021-2026) & (K Units) Table 143. Europe Vigabatrin Sales by Application (2027-2032) & (K Units) Table 144. Europe Vigabatrin Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Vigabatrin Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Vigabatrin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Vigabatrin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Vigabatrin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Vigabatrin Sales by Country (2021-2026) & (K Units) Table 151. Europe Vigabatrin Sales by Country (2027-2032) & (K Units) Table 152. Europe Vigabatrin Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Vigabatrin Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Vigabatrin Revenue (2021-2032) & (US$ Million) Table 155. France Vigabatrin Revenue (2021-2032) & (US$ Million) Table 156. U.K. Vigabatrin Revenue (2021-2032) & (US$ Million) Table 157. Italy Vigabatrin Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Vigabatrin Revenue (2021-2032) & (US$ Million) Table 159. China Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 160. China Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 161. China Vigabatrin Sales by Type (2021-2026) & (K Units) Table 162. China Vigabatrin Sales by Type (2027-2032) & (K Units) Table 163. China Vigabatrin Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Vigabatrin Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 166. China Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 167. China Vigabatrin Sales by Application (2021-2026) & (K Units) Table 168. China Vigabatrin Sales by Application (2027-2032) & (K Units) Table 169. China Vigabatrin Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Vigabatrin Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Vigabatrin Sales by Type (2021-2026) & (K Units) Table 174. Asia Vigabatrin Sales by Type (2027-2032) & (K Units) Table 175. Asia Vigabatrin Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Vigabatrin Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Vigabatrin Sales by Application (2021-2026) & (K Units) Table 180. Asia Vigabatrin Sales by Application (2027-2032) & (K Units) Table 181. Asia Vigabatrin Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Vigabatrin Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Vigabatrin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Vigabatrin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Vigabatrin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Vigabatrin Sales by Country (2021-2026) & (K Units) Table 188. Asia Vigabatrin Sales by Country (2027-2032) & (K Units) Table 189. Asia Vigabatrin Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Vigabatrin Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Vigabatrin Revenue (2021-2032) & (US$ Million) Table 192. South Korea Vigabatrin Revenue (2021-2032) & (US$ Million) Table 193. India Vigabatrin Revenue (2021-2032) & (US$ Million) Table 194. Australia Vigabatrin Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Vigabatrin Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Vigabatrin Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Vigabatrin Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Vigabatrin Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Vigabatrin Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Vigabatrin Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Vigabatrin Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Vigabatrin Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Vigabatrin Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Vigabatrin Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Vigabatrin Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Vigabatrin Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Vigabatrin Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Vigabatrin Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Vigabatrin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Vigabatrin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Vigabatrin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Vigabatrin Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Vigabatrin Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Vigabatrin Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Vigabatrin Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Vigabatrin Revenue (2021-2032) & (US$ Million) Table 218. Argentina Vigabatrin Revenue (2021-2032) & (US$ Million) Table 219. Chile Vigabatrin Revenue (2021-2032) & (US$ Million) Table 220. Colombia Vigabatrin Revenue (2021-2032) & (US$ Million) Table 221. Peru Vigabatrin Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Vigabatrin Revenue (2021-2032) & (US$ Million) Table 223. Israel Vigabatrin Revenue (2021-2032) & (US$ Million) Table 224. UAE Vigabatrin Revenue (2021-2032) & (US$ Million) Table 225. Turkey Vigabatrin Revenue (2021-2032) & (US$ Million) Table 226. Iran Vigabatrin Revenue (2021-2032) & (US$ Million) Table 227. Egypt Vigabatrin Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Vigabatrin Distributors List Table 231. Vigabatrin Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Vigabatrin Image Figure 2. Global Vigabatrin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vigabatrin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Powder Image Figure 6. Global Vigabatrin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Vigabatrin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Partial-Onset Seizures Image Figure 9. Refractory Complex Partial Seizures Image Figure 10. Infantile Spasms (IS) Image Figure 11. Global Vigabatrin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Vigabatrin Revenue (2021-2032) & (US$ Million) Figure 13. Global Vigabatrin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Vigabatrin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Vigabatrin Revenue Market Share by Region (2021-2032) Figure 16. Global Vigabatrin Sales (2021-2032) & (K Units) Figure 17. Global Vigabatrin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Vigabatrin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Vigabatrin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Vigabatrin Sales YoY (2021-2032) & (K Units) Figure 21. China Vigabatrin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Vigabatrin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Vigabatrin Sales YoY (2021-2032) & (K Units) Figure 24. Global Vigabatrin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Vigabatrin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Vigabatrin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Vigabatrin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Vigabatrin Revenue Market Share by Type (2021-2032) Figure 30. Global Vigabatrin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Vigabatrin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Vigabatrin Sales Market Share by Type (2021-2032) Figure 33. Global Vigabatrin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Vigabatrin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Vigabatrin Revenue Market Share by Application (2021-2032) Figure 36. Global Vigabatrin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Vigabatrin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Vigabatrin Sales Market Share by Application (2021-2032) Figure 39. North America Vigabatrin Revenue Share by Type (2021-2032) Figure 40. North America Vigabatrin Sales Share by Type (2021-2032) Figure 41. North America Vigabatrin Revenue Share by Application (2021-2032) Figure 42. North America Vigabatrin Sales Share by Application (2021-2032) Figure 43. North America Vigabatrin Revenue Share by Country (2021-2032) Figure 44. North America Vigabatrin Sales Share by Country (2021-2032) Figure 45. Europe Vigabatrin Revenue Share by Type (2021-2032) Figure 46. Europe Vigabatrin Sales Share by Type (2021-2032) Figure 47. Europe Vigabatrin Revenue Share by Application (2021-2032) Figure 48. Europe Vigabatrin Sales Share by Application (2021-2032) Figure 49. Europe Vigabatrin Revenue Share by Country (2021-2032) Figure 50. Europe Vigabatrin Sales Share by Country (2021-2032) Figure 51. China Vigabatrin Revenue Share by Type (2021-2032) Figure 52. China Vigabatrin Sales Share by Type (2021-2032) Figure 53. China Vigabatrin Revenue Share by Application (2021-2032) Figure 54. China Vigabatrin Sales Share by Application (2021-2032) Figure 55. Asia Vigabatrin Revenue Share by Type (2021-2032) Figure 56. Asia Vigabatrin Sales Share by Type (2021-2032) Figure 57. Asia Vigabatrin Revenue Share by Application (2021-2032) Figure 58. Asia Vigabatrin Sales Share by Application (2021-2032) Figure 59. Asia Vigabatrin Revenue Share by Country (2021-2032) Figure 60. Asia Vigabatrin Sales Share by Country (2021-2032) Figure 61. SAMEA Vigabatrin Revenue Share by Type (2021-2032) Figure 62. SAMEA Vigabatrin Sales Share by Type (2021-2032) Figure 63. SAMEA Vigabatrin Revenue Share by Application (2021-2032) Figure 64. SAMEA Vigabatrin Sales Share by Application (2021-2032) Figure 65. SAMEA Vigabatrin Revenue Share by Country (2021-2032) Figure 66. SAMEA Vigabatrin Sales Share by Country (2021-2032) Figure 67. Vigabatrin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Vigabatrin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Powder
Applications
  • Partial-Onset Seizures
  • Refractory Complex Partial Seizures
  • Infantile Spasms (IS)
Companies covered
  • Sanofi
  • Novartis
  • Upsher-Smith
  • Perrigo
  • Lundbeck
  • Grindeks
  • Endo International
  • Dr. Fisher Farma
  • Cipla
  • Benta Pharma Industries
  • Amneal Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vigabatrin Market by Type
  3. 1.2.1 Global Vigabatrin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Powder
  6. 1.3 Vigabatrin Market by Application
  7. 1.3.1 Global Vigabatrin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Partial-Onset Seizures
  9. 1.3.3 Refractory Complex Partial Seizures
  10. 1.3.4 Infantile Spasms (IS)
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Vigabatrin Market Dynamics
  1. 2.1 Vigabatrin Industry Trends
  2. 2.2 Vigabatrin Industry Drivers
  3. 2.3 Vigabatrin Industry Opportunities and Challenges
  4. 2.4 Vigabatrin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vigabatrin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vigabatrin Revenue by Region
  3. 3.2.1 Global Vigabatrin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vigabatrin Revenue by Region (2021-2026)
  5. 3.2.3 Global Vigabatrin Revenue by Region (2027-2032)
  6. 3.2.4 Global Vigabatrin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vigabatrin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vigabatrin Sales by Region
  9. 3.4.1 Global Vigabatrin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vigabatrin Sales by Region (2021-2026)
  11. 3.4.3 Global Vigabatrin Sales by Region (2027-2032)
  12. 3.4.4 Global Vigabatrin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vigabatrin Revenue by Manufacturers
  2. 4.1.1 Global Vigabatrin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vigabatrin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vigabatrin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vigabatrin Sales by Manufacturers
  6. 4.2.1 Global Vigabatrin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vigabatrin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vigabatrin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vigabatrin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vigabatrin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vigabatrin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vigabatrin Manufacturers, Product Type & Application
  13. 4.7 Global Vigabatrin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vigabatrin Market CR5 and HHI
  16. 4.8.2 2025 Vigabatrin Tier 1, Tier 2, and Tier 3
5 Vigabatrin Market by Type
  1. 5.1 Global Vigabatrin Revenue by Type
  2. 5.1.1 Global Vigabatrin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vigabatrin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vigabatrin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vigabatrin Sales by Type
  6. 5.2.1 Global Vigabatrin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vigabatrin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Vigabatrin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vigabatrin Price by Type
6 Vigabatrin Market by Application
  1. 6.1 Global Vigabatrin Revenue by Application
  2. 6.1.1 Global Vigabatrin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vigabatrin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vigabatrin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vigabatrin Sales by Application
  6. 6.2.1 Global Vigabatrin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vigabatrin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Vigabatrin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vigabatrin Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Vigabatrin Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Vigabatrin Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Upsher-Smith
  14. 7.3.1 Upsher-Smith Company Information
  15. 7.3.2 Upsher-Smith Business Overview
  16. 7.3.3 Upsher-Smith Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Upsher-Smith Vigabatrin Product Portfolio
  18. 7.3.5 Upsher-Smith Recent Developments
  19. 7.4 Perrigo
  20. 7.4.1 Perrigo Company Information
  21. 7.4.2 Perrigo Business Overview
  22. 7.4.3 Perrigo Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Perrigo Vigabatrin Product Portfolio
  24. 7.4.5 Perrigo Recent Developments
  25. 7.5 Lundbeck
  26. 7.5.1 Lundbeck Company Information
  27. 7.5.2 Lundbeck Business Overview
  28. 7.5.3 Lundbeck Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lundbeck Vigabatrin Product Portfolio
  30. 7.5.5 Lundbeck Recent Developments
  31. 7.6 Grindeks
  32. 7.6.1 Grindeks Company Information
  33. 7.6.2 Grindeks Business Overview
  34. 7.6.3 Grindeks Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Grindeks Vigabatrin Product Portfolio
  36. 7.6.5 Grindeks Recent Developments
  37. 7.7 Endo International
  38. 7.7.1 Endo International Company Information
  39. 7.7.2 Endo International Business Overview
  40. 7.7.3 Endo International Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Endo International Vigabatrin Product Portfolio
  42. 7.7.5 Endo International Recent Developments
  43. 7.8 Dr. Fisher Farma
  44. 7.8.1 Dr. Fisher Farma Company Information
  45. 7.8.2 Dr. Fisher Farma Business Overview
  46. 7.8.3 Dr. Fisher Farma Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dr. Fisher Farma Vigabatrin Product Portfolio
  48. 7.8.5 Dr. Fisher Farma Recent Developments
  49. 7.9 Cipla
  50. 7.9.1 Cipla Company Information
  51. 7.9.2 Cipla Business Overview
  52. 7.9.3 Cipla Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Cipla Vigabatrin Product Portfolio
  54. 7.9.5 Cipla Recent Developments
  55. 7.10 Benta Pharma Industries
  56. 7.10.1 Benta Pharma Industries Company Information
  57. 7.10.2 Benta Pharma Industries Business Overview
  58. 7.10.3 Benta Pharma Industries Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Benta Pharma Industries Vigabatrin Product Portfolio
  60. 7.10.5 Benta Pharma Industries Recent Developments
  61. 7.11 Amneal Pharma
  62. 7.11.1 Amneal Pharma Company Information
  63. 7.11.2 Amneal Pharma Business Overview
  64. 7.11.3 Amneal Pharma Vigabatrin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Amneal Pharma Vigabatrin Product Portfolio
  66. 7.11.5 Amneal Pharma Recent Developments
8 North America
  1. 8.1 North America Vigabatrin Market Size by Type
  2. 8.1.1 North America Vigabatrin Revenue by Type (2021-2032)
  3. 8.1.2 North America Vigabatrin Sales by Type (2021-2032)
  4. 8.1.3 North America Vigabatrin Price by Type (2021-2032)
  5. 8.2 North America Vigabatrin Market Size by Application
  6. 8.2.1 North America Vigabatrin Revenue by Application (2021-2032)
  7. 8.2.2 North America Vigabatrin Sales by Application (2021-2032)
  8. 8.2.3 North America Vigabatrin Price by Application (2021-2032)
  9. 8.3 North America Vigabatrin Market Size by Country
  10. 8.3.1 North America Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vigabatrin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vigabatrin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Vigabatrin Market Size by Type
  2. 9.1.1 Europe Vigabatrin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vigabatrin Sales by Type (2021-2032)
  4. 9.1.3 Europe Vigabatrin Price by Type (2021-2032)
  5. 9.2 Europe Vigabatrin Market Size by Application
  6. 9.2.1 Europe Vigabatrin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vigabatrin Sales by Application (2021-2032)
  8. 9.2.3 Europe Vigabatrin Price by Application (2021-2032)
  9. 9.3 Europe Vigabatrin Market Size by Country
  10. 9.3.1 Europe Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vigabatrin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vigabatrin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Vigabatrin Market Size by Type
  2. 10.1.1 China Vigabatrin Revenue by Type (2021-2032)
  3. 10.1.2 China Vigabatrin Sales by Type (2021-2032)
  4. 10.1.3 China Vigabatrin Price by Type (2021-2032)
  5. 10.2 China Vigabatrin Market Size by Application
  6. 10.2.1 China Vigabatrin Revenue by Application (2021-2032)
  7. 10.2.2 China Vigabatrin Sales by Application (2021-2032)
  8. 10.2.3 China Vigabatrin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vigabatrin Market Size by Type
  2. 11.1.1 Asia Vigabatrin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vigabatrin Sales by Type (2021-2032)
  4. 11.1.3 Asia Vigabatrin Price by Type (2021-2032)
  5. 11.2 Asia Vigabatrin Market Size by Application
  6. 11.2.1 Asia Vigabatrin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vigabatrin Sales by Application (2021-2032)
  8. 11.2.3 Asia Vigabatrin Price by Application (2021-2032)
  9. 11.3 Asia Vigabatrin Market Size by Country
  10. 11.3.1 Asia Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vigabatrin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vigabatrin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vigabatrin Market Size by Type
  2. 12.1.1 SAMEA Vigabatrin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vigabatrin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vigabatrin Price by Type (2021-2032)
  5. 12.2 SAMEA Vigabatrin Market Size by Application
  6. 12.2.1 SAMEA Vigabatrin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vigabatrin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vigabatrin Price by Application (2021-2032)
  9. 12.3 SAMEA Vigabatrin Market Size by Country
  10. 12.3.1 SAMEA Vigabatrin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vigabatrin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vigabatrin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vigabatrin Value Chain Analysis
  2. 13.1.1 Vigabatrin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vigabatrin Production Mode & Process
  6. 13.2 Vigabatrin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vigabatrin Distributors
  9. 13.2.3 Vigabatrin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst